Dr. Kelly Huang

Kelly Huang, Ph.D. brings extensive experience leading global businesses through the integration of scientific, consumer, and professional insights to create value by putting the customer and patient at the center. Most recently, he was a member of $3B Endo Health Solutions’ (Nasdaq: ENDP) Executive Committee responsible for strategic leadership across the Branded & Generics Pharmaceuticals, Medical Devices, and Medical Services sectors. Dr. Huang had direct accountability for financial performance and overall leadership of Medical Services with the $200M+ HealthTronics subsidiary. Kelly is a valued advisor to the Spindletop team.

With Endo’s shift to a solutions strategy, he broadened HealthTronics beyond surgical services to data-enabled applications and solutions that improve patient outcomes and practice economics. This was accomplished through acquisition of MeridianEMR and IMS/UroChart electronic health record companies, Trellis Healthcare business intelligence company, and collaboration with CareCloud for integrated practice management software. Upon the systems foundation, Dr. Huang built capabilities in analytics and consulting services to enable new business models that network physicians into a data-enabled channel.

Prior to joining Endo, Dr. Huang spent 16 years with Johnson & Johnson. He held the position of Vice President of Research & Development and was a corporate officer of Neutrogena Corporation, a J&J company. Prior to Neutrogena in 2009, as Vice President with J&J’s Development Corporation since 2006, Dr. Huang established and headed an Internal Venture to develop a transformational delivery platform based on genetic engineering for discovery and design of novel proteins. In addition, he held leadership positions within J&J’s Consumer Healthcare business, which included spending two years in Paris, France, that drove innovation globally. He obtained his Doctorate and Masters degrees in Chemical Engineering from StanfordUniversity in California. He also holds a Bachelors degree in Chemical Engineering, with a minor in Chemistry, from the University of Massachusetts at Amherst. Kelly holds board positions on the Texas eHealth Alliance and the Editorial Board of American Drug and Health Benefits.